Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer

Last 30 days: 42 accesses
Last 365 days: 437 accesses
All time: 2172 accesses

Yong S Hong^†, Hyeon J Cho^†, Sun Y Kim, Kyung H Jung, Ji W Park, Hyo S Choi, Jae H Oh, Byung C Kim, Dae K Sohn, Dae Y Kim and Hee J Chang^*